Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
42
PPERY Quote, Financials, Valuation and Earnings
Last price:
$12.29
Seasonality move
:
1.85%
Day range:
$12.04 - $12.18
52-week range:
$10.25 - $20.07
Dividend yield:
9.13%
P/E ratio:
--
P/S ratio:
3.30x
P/B ratio:
1.92x
Volume:
76.5K
Avg. volume:
116.2K
1-year change:
-21.83%
Market cap:
$28.2B
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, PT Bank Mandiri (Persero) Tbk has -- downside to fair value with a price target of -- per share.
PPERY vs. S&P 500
-
Over the past 5 trading days, PT Bank Mandiri (Persero) Tbk has overperformed the S&P 500 by 2.18% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
PT Bank Mandiri (Persero) Tbk does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PT Bank Mandiri (Persero) Tbk has grown year-over-year revenues for 9 quarters straight. In the most recent quarter PT Bank Mandiri (Persero) Tbk reported revenues of --.
Earnings Growth
-
PT Bank Mandiri (Persero) Tbk has grown year-over-year earnings for 7 quarters straight. In the most recent quarter PT Bank Mandiri (Persero) Tbk reported earnings per share of --.
Enterprise value:
18.7B
EV / Invested capital:
--
Price / LTM sales:
3.30x
EV / EBIT:
3.61x
EV / Revenue:
2.19x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
2.97x
Price / Operating cash flow:
4.47x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2021-12-31 | 2022-12-31 | |
| Income Statement | ||||||
| Revenue | $6.8B | $7.8B | $8.5B | $2.2B | $2.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.50 | $0.84 | $1.19 | $0.26 | $0.29 | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.6B | $12.4B | $20.5B | $19B | $22.2B | |
| Total Assets | $83B | $94.9B | $107.9B | $120.8B | $127.5B | |
| Current Liabilities | $251M | $266.8M | $427.2M | $388.1M | $773.4M | |
| Total Liabilities | $70.2B | $79.9B | $93.6B | $105.2B | $111.4B | |
| Total Equity | $12.8B | $15.1B | $14.3B | $15.5B | $16.1B | |
| Total Debt | $4.7B | $6.1B | $6.3B | $6.6B | $6.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2021-12-31 | 2022-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.6B | $9B | $6.8B | $3.4B | $6.3B | |
| Cash From Investing | -$2.9B | -$9.2B | -$2.9B | -$1.8B | -$389.1M | |
| Cash From Financing | -$992.6M | -$239.2M | $897.8M | $363.6M | $119.7M | |
| Free Cash Flow | $7.1B | $8.7B | $6.3B | $3.2B | $6.1B | |
PPERY
Sector
Market Cap
$28.2B
$600.8M
Price % of 52-Week High
60.14%
84.99%
Dividend Yield
9.13%
2%
Shareholder Yield
--
3.99%
1-Year Price Total Return
-21.83%
8.34%
Beta (5-Year)
0.510
0.590
Dividend yield:
9.13%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$11.82
200-day SMA
Sell
Level
$15.09
Bollinger Bands (100)
Sell
Level
11.41 - 14.33
Chaikin Money Flow
Buy
Level
13.4M
20-day SMA
Buy
Level
$11.56
Relative Strength Index (RSI14)
Buy
Level
55.73
ADX Line
Buy
Level
11.7
Williams %R
Sell
Level
-9.7701
50-day SMA
Buy
Level
$11.65
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
15.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PT Bank Mandiri (Persero) Tbk is a full-service bank principally operating in the Indonesian archipelago. The national government of Indonesia owns well over half of the bank's outstanding shares. Its various products and services includes deposit collection, loans, promissory note issuance, guarantee services, wholesale banking, custodian banking, asset and wealth management, factoring and credit card services, and Islamic banking. The bank emphasizes a cross-selling culture and increased regionalization, expertise-oriented solutions, and ease of access for its micro, small, and midsize enterprise customers. Its loan portfolio is diversified, mostly in industrials, restaurants and hospitality, and the transportation and storage industries.
Stock Forecast FAQ
In the current month, PPERY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PPERY average analyst price target in the past 3 months is --.
-
Where Will PT Bank Mandiri (Persero) Tbk Stock Be In 1 Year?
According to analysts, the consensus estimate is that PT Bank Mandiri (Persero) Tbk share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PT Bank Mandiri (Persero) Tbk?
Analysts are divided on their view about PT Bank Mandiri (Persero) Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Bank Mandiri (Persero) Tbk is a Sell and believe this share price will rise from its current level to --.
-
What Is PT Bank Mandiri (Persero) Tbk's Price Target?
The price target for PT Bank Mandiri (Persero) Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PPERY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PT Bank Mandiri (Persero) Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PPERY?
You can purchase shares of PT Bank Mandiri (Persero) Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Bank Mandiri (Persero) Tbk shares.
-
What Is The PT Bank Mandiri (Persero) Tbk Share Price Today?
PT Bank Mandiri (Persero) Tbk was last trading at $12.29 per share. This represents the most recent stock quote for PT Bank Mandiri (Persero) Tbk. Yesterday, PT Bank Mandiri (Persero) Tbk closed at $12.07 per share.
-
How To Buy PT Bank Mandiri (Persero) Tbk Stock Online?
In order to purchase PT Bank Mandiri (Persero) Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 92.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 3.94% over the past day.
